Stock Analysis
Agilent Technologies Inc.A
P/E 33.86×· 5Y range 22.21–53.94×· 78th percentile of history
Sector: Technology · Industry: Laboratory Analytical Instruments
AnalystsStrong Buy30 analystsP/E 33.9× sits at the 78th percentile of its 5.089664613278576-year history.
Cash covers 52% of debt · Q1 2026.
PMP Verdict
High quality, but expensive
Strengths
- Financial Health87
- Quality82
Risks
- Valuation27
- Growth43
Excellent business. Weak entry price.
Bull Case
- ✓Altman Z 5.7 — safe-zone balance sheet
- ✓ROE 20.8% — efficient capital deployment
- ✓Interest coverage 15.1× — debt well covered
What's happening with A
Profile
Strong moat, financial health, earnings quality and profitability; valuation and growth lag behind.
How is each axis scored?
- Valuation27/100 · Weak
- P/E vs own history (78th pct)5/25
- FCF yield (2.6%)5/25
- P/S (6.6x)12/25
- EV/EBIT (30.7x)5/25
- Growth43/100 · Weak
- Revenue CAGR (2.4%)6/25
- Net income CAGR (1.9%)6/25
- EPS CAGR 5Y (3.8%)6/25
- Fwd implied growth (35.7%)25/25
- Profitability80/100 · Strong
- ROIC (15.2%)20/25
- ROE (20.8%)20/25
- Net margin (19.5%)20/25
- Operating margin (22.2%)20/25
- Financial Health87/100 · Strong
- Altman Z (5.67)25/25
- Current ratio (2.07)25/25
- Interest coverage (15.1x)25/25
- Net cash / debt (D/A 12%)12/25
- Quality82/100 · Strong
- Piotroski F (6/9)15/25
- Beneish M (-2.42)20/25
- FCF conversion (88%)22/25
- Margin stability (σ 3.0%)25/25
- Moat88/100 · Strong
- ROIC >12% years (9/10 yrs)25/25
- Median gross margin (53.9%)20/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst 6.4%)18/25
About Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Show more
Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Headquarters: SANTA CLARA, CA · Employees: 18,200 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
27EP/E (TTM)33.9xC
Grade C: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 22.2x–53.9x · 78th pct
P/FCF38.9xC
Grade C: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield2.6%C
Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 2.1%–4.7% · 15th pct
P/S (TTM)6.62xC
Grade C: ExpensivePrice / TTM Revenue (own statements) — vs own 5Y history: 4.3x–8.7x · 85th pct
EV/EBIT30.7xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 20.5x–43.8x · 79th pct
EV/Sales7.0xC
Grade C: ExpensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E25.0xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio7.06xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio3.61D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield0.58%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio19.9%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
80AROIC15.2%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE20.8%A
Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks
ROA11.0%A
Grade A: StrongReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin19.5%A
Grade A: HighNet Income / Revenue
Operating Margin22.2%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin53.8%A
Grade A: PremiumGross Profit / Revenue
FCF Margin17.2%A
Grade A: HighFCF / Revenue
True FCF Margin15.4%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
43D+Revenue CAGR2.4%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR1.9%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)3.8%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth35.7%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-8.2%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income9.1%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue1.8%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
87AAltman Z-Score5.67A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio2.07xA
Grade A: HighCurrent Assets/Liabilities
Quick Ratio1.56xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage15.1xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment1.3yA
Grade A: FastYears to repay net debt via FCF
Net Debt/EBIT1.0xA
Grade A: LowLeverage. <2x Low, >4x High
Debt/Equity0.49xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.52xC
Grade C: PartialCash covers how much of total debt. >1 = could repay all debt from cash
Quality
82APiotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.42A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion88.0%A
Grade A: StrongFCF / Net Income
Margin Stability3.0%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue4.6%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.56xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Boehnlein Glenn S Filed | Boehnlein Glenn S | Grant / award | +817 | |
Dolsten Mikael Filed | Dolsten Mikael | SellOpen market sale | -634 | |
MCDONNELL PADRAIG Filed | MCDONNELL PADRAIG | Tax withholding | -418 | |
Dolsten Mikael Filed | Dolsten Mikael | SellOpen market sale | -1600 | |
Buckner Michael Steven Filed | Buckner Michael Steven | Grant / award | +8.9K |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
MAY SIMON Filed | MAY SIMON | Tax withholding | -368 | |
Henson Meghan Filed | Henson Meghan | Tax withholding | -153 | |
Rataj Sue H. Filed | Rataj Sue H. | Grant / award | +2.2K |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
88AROIC >12% Years9/10 yrsA
Grade A: DurableShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)53.9%A
Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor6.4%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$5.11
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$6.23
Cash & short-term investments per share (Finnhub)
Book Value / Share$26.11
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$3.35B
Total debt obligations (short + long term)
Cash & Equiv.$1.76B
Cash and short-term investments
Net Debt$1.60B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$6.91B
Shareholders' equity (book value)
Asset / Liability2.17xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$48.77B
Current Market Capitalization
Beta1.25C
Grade C: VolatilePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jul 2026 · Ratio snapshot Oct 16, 2026
Key Insights: Agilent Technologies Inc. (A)
A is down 1.47% at the last close. Piotroski F-Score of 6/9 indicates mixed fundamentals for Agilent Technologies Inc.. Altman Z-Score of 5.67 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of -2.42 suggests a low likelihood of earnings manipulation.
- Agilent Technologies Inc. converts about 17% of revenue into free cash flow — strong cash generation.
- Takes ~1.3 years to repay net debt from free cash flow.
- At a valuation score of 27/100, A trades at a premium to its historical multiples (P/E 33.9).
- Return on equity of 20.8% is well above the market average.
See how A ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all A moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 24 | Regular | 174.42 | +5.50% | 2.61 |
| Sep 24 | After-hours | 173.00 | +4.65% | 2.18 |
Frequently Asked Questions about A
What is the current Agilent Technologies Inc. (A) stock price?
A is trading at $172.97 at the last market close, down 1.47% on the session. PreMarketPrice tracks A pre-market, intraday and after-hours prices.
Is A stock a buy right now?
PreMarketPrice's quantitative model rates Agilent Technologies Inc.'s financial health at 87/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is A stock overvalued?
Agilent Technologies Inc. trades at a trailing P/E of 33.9 and our valuation score rates it 27/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Agilent Technologies Inc. report earnings?
No confirmed earnings date is currently scheduled for A. The Earnings section lists recent reports and updates as dates are announced.
What sector does Agilent Technologies Inc. operate in?
Agilent Technologies Inc. operates in the Technology sector, within the Laboratory Analytical Instruments industry. The Related Stocks section lists sector peers for comparison.
What does Agilent Technologies Inc. do?
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm.
About Agilent Technologies Inc. (A) Stock
Agilent Technologies Inc. (A) is a US-listed stock operating in the Technology sector, specifically the Laboratory Analytical Instruments industry. As of the latest update, Agilent Technologies Inc. is trading at $172.97, down 1.47% on the day with a market capitalization of $48.8 billion. The financial health score for A is 87/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for A stock.
A Stock Analysis & Key Metrics
On PreMarketPrice, you can track Agilent Technologies Inc. (A) across multiple dimensions:
- Pre-market price & movement: Real-time A stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for A with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Agilent Technologies Inc. across multiple reporting periods.
- Financial health score: A composite score of 87/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for A.
- Sector peers: Compare A against 6 other technology stocks on key financial metrics.
Is A a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Agilent Technologies Inc. (A) as an investment. The financial health score of 87/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Agilent Technologies Inc. (A) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.